Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Postphlebitic Syndrome

ClinicalTrials.gov lists 7 trials for Postphlebitic Syndrome or a narrower condition beneath it.

MeSH D011186 Cardiovascular Diseases C14
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 3 Phase 3 3 Not applicable Not applicable 2 Observational Observational 2 Phase 3 Phase 3 3 Not applicable Not applicable 2 Observational Observational 2

Trials per phase

7 of the 7 trials are tagged with Postphlebitic Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Postphlebitic Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Postphlebitic Syndrome trials start? (3)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 3
  • Not applicable
  • Observational

Top of scale: 4

2004: 4 trials (Observational 2, Phase 3 2) 2006: 1 trials (Not applicable 1) 2009: 2 trials (Not applicable 1, Phase 3 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2009 2
2006 1
2004 4

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Postphlebitic Syndrome trials in? (3)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 3 3
Not applicable 2
Observational 2

How many Postphlebitic Syndrome trials are recruiting? (2)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Completed 6
Withdrawn 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which serious adverse events do Postphlebitic Syndrome trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Deep vein thrombosis 42 1
Chest pain 17 1
Pulmonary embolism 17 1
Gastrointestinal bleed 14 1
Cellulitis 10 1

Which publications cover Postphlebitic Syndrome? (21)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages